Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Ultragenyx Pharmaceutical Inc. (RARE) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 4 Horn Howard (CFO) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Granted 80,366 shares @ $0
Granted 140,469 options to buy @ $35.68, valued at $5M
10/10/2023 3 Horn Howard (CFO) has filed a Form 3 on Ultragenyx Pharmaceutical Inc.
09/29/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/29/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/30/2023 4 Sanders Corazon (Corsee) D. (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Sold 585 shares @ $46.76, valued at $27.4k
06/09/2023 4 Ray Amrit (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Granted 3,860 shares @ $0
Granted 7,110 options to buy @ $51.82, valued at $368.4k
06/09/2023 4 Fust Matthew K (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Granted 3,860 shares @ $0
Disposed/sold 3,300 shares @ $51.82, valued at $171k
Granted 7,110 options to buy @ $51.82, valued at $368.4k
06/09/2023 4 Sanders Corazon (Corsee) D. (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Granted 3,860 shares @ $0
Sold 1,485 shares @ $51.65, valued at $76.7k
Granted 7,110 options to buy @ $51.82, valued at $368.4k
06/09/2023 4 SULIMAN SHEHNAAZ (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Granted 3,860 shares @ $0
Granted 7,110 options to buy @ $51.82, valued at $368.4k
06/09/2023 4 NARACHI MICHAEL (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Granted 3,860 shares @ $0
Granted 7,110 options to buy @ $51.82, valued at $368.4k
06/09/2023 4 Dunsire Deborah (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Granted 3,860 shares @ $0
Granted 7,110 options to buy @ $51.82, valued at $368.4k
06/09/2023 4 WELCH DANIEL G (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Granted 3,860 shares @ $0
Granted 7,110 options to buy @ $51.82, valued at $368.4k
05/19/2023 4 Pinion John Richard (See Remarks) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Sold 2,012 shares @ $50, valued at $100.6k
05/10/2023 4 Huizenga Theodore Alan (SVP, Chief Accounting Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Exercised 3,000 options to buy @ $21, valued at $63k
05/05/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/02/2023 4 Crombez Eric (EVP and Chief Medical Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Granted 4,658 shares @ $0
Granted 8,362 options to buy @ $44.03, valued at $368.2k
05/02/2023 3 Crombez Eric (EVP and Chief Medical Officer) has filed a Form 3 on Ultragenyx Pharmaceutical Inc.
04/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2023 4 Bedrosian Camille L (EVP and Chief Medical Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Granted 2,663 shares @ $0
Sold 3,881 shares @ $45.25, valued at $175.6k
03/03/2023 4 Parschauer Karah Herdman (EVP and Chief Legal Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Granted 2,663 shares @ $0
Granted 22,000 shares @ $0
Sold 3,161 shares @ $45.25, valued at $143k
Granted 39,400 options to buy @ $45.65, valued at $1.8M
03/03/2023 4 Kassberg Thomas Richard (CBO & EVP) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Granted 2,663 shares @ $0
Granted 22,000 shares @ $0
Sold 1,968 shares @ $45.27, valued at $89.1k
Disposed/sold 3,394 shares @ $45.65, valued at $154.9k
Granted 39,400 options to buy @ $45.65, valued at $1.8M
03/03/2023 4 Huizenga Theodore Alan (SVP, Chief Accounting Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Granted 7,590 shares @ $0
Sold 100 shares @ $45.65, valued at $4.6k
Disposed/sold 1,333 shares @ $45.65, valued at $60.9k
Granted 10,120 options to buy @ $45.65, valued at $462k
03/03/2023 4 Huang Dennis Karl (See Remarks) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Granted 2,663 shares @ $0
Granted 22,000 shares @ $0
Sold 389 shares @ $45.65, valued at $17.8k
Disposed/sold 10,599 shares @ $45.65, valued at $483.8k
Granted 39,400 options to buy @ $45.65, valued at $1.8M
03/03/2023 4 Pinion John Richard (See Remarks) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Granted 2,663 shares @ $0
Granted 22,000 shares @ $0
Sold 3,755 shares @ $45.26, valued at $170k
Disposed/sold 4,014 shares @ $45.65, valued at $183.2k
Granted 39,400 options to buy @ $45.65, valued at $1.8M
03/03/2023 4 KAKKIS EMIL D (President & CEO) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Granted 8,716 shares @ $0
Granted 46,200 shares @ $0
Paid exercise price by delivering 16,140 shares @ $45.65, valued at $736.8k
Granted 83,500 options to buy @ $45.65, valued at $3.8M
03/03/2023 4 Harris Erik (EVP & Chief Commercial Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Granted 2,663 shares @ $0
Granted 22,000 shares @ $0
Sold 3,664 shares @ $45.25, valued at $165.8k
Granted 39,400 options to buy @ $45.65, valued at $1.8M
03/02/2023 4 Huizenga Theodore Alan (SVP, Chief Accounting Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Sold 639 shares @ $43.4, valued at $27.7k
01/03/2023 4 KAKKIS EMIL D (President & CEO) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Sold 19,582 shares @ $45.57, valued at $892.4k
12/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/17/2022 4 Dier Mardi (CFO & Executive Vice President) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Sold 1,629 shares @ $40.16, valued at $65.4k
10/14/2022 4 Dier Mardi (CFO & Executive Vice President) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Sold 3,484 shares @ $38.22, valued at $133.2k
09/19/2022 4 Dier Mardi (CFO & Executive Vice President) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Granted 20,000 shares @ $0
09/08/2022 4 Huizenga Theodore Alan (SVP, Chief Accounting Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Granted 1,000 shares @ $0
06/29/2022 4 Sanders Corazon (Corsee) D. (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Granted 3,300 shares @ $0
Granted 6,245 options to buy @ $60.57, valued at $378.3k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy